The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- Morocco welcomes 14% more Brazilian tourists
- Brazilian education company now in Qatar
- Saudi Arabia’s non-oil GDP grows 0.6%
- Brazil-Arab Gallery #67
- BIG Studios partners with Arab producer
- Dubai’s Amazing Creation enters Brazilian market
- Brazil-Arab Gallery #66
- Fertilizer costs weigh on Brazil’s ag logistics

